IRF4 is required for migration of CD4+ T cells to the intestine but not for Th2 and Th17 cell maintenance

Standard

IRF4 is required for migration of CD4+ T cells to the intestine but not for Th2 and Th17 cell maintenance. / Schmidt, Constantin; Harberts, Aenne; Reimers, Daniel; Bertram, Tabea; Voß, Leonie Caroline; Schmid, Joanna; Lory, Niels Christian; Spohn, Michael; Koch-Nolte, Friedrich; Huber, Samuel; Raczkowski, Friederike; Breloer, Minka; Mittrücker, Hans-Willi.

In: FRONT IMMUNOL, Vol. 14, 2023, p. 1182502.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{8122839920334c11812e78d9ae27e329,
title = "IRF4 is required for migration of CD4+ T cells to the intestine but not for Th2 and Th17 cell maintenance",
abstract = "The transcription factor Interferon Regulatory Factor 4 (IRF4) is central in control of T cell activation and differentiation. Deficiency of IRF4 results in severe immune deficiency and affects maturation and function of most if not all T cell subsets. Here we use mouse infection models for Citrobacter rodentium and Strongyloides ratti to analyze the function of IRF4 in T helper (Th) 17 and Th2 cell responses, respectively. IRF4 deficient mice were impaired in the control of both pathogens, failed to mount Th17 and Th2 cell responses and showed impaired recruitment of T helper cells to the intestine, the infection site of both pathogens. Compromised intestinal migration was associated with reduced expression of the intestinal homing receptors α4β7 integrin, CCR9 and GPR15. Identification of IRF4 binding sites in the gene loci of these receptors suggests a direct control of their expression by IRF4. Competitive T cell transfer assays further demonstrated that loss of one functional Irf4 allele already affected intestinal accumulation and Th2 and Th17 cell generation, indicating that lower IRF4 levels are of disadvantage for Th2 and Th17 cell differentiation as well as their migration to the intestine. Conversion of peripheral CD4+ T cells from an Irf4 wildtype to an Irf4 heterozygous or from an Irf4 heterozygous to a homozygous mutant genotype after C. rodentium or S. ratti infection did not reduce their capacity to produce Th17 or Th2 cytokines and only partially affected their persistence in the intestine, revealing that IRF4 is not essential for maintenance of the Th2 and Th17 phenotype and for survival of these T helper cells in the intestine. In conclusion, we demonstrate that the expression levels of IRF4 determine Th2 and Th17 cell differentiation and their intestinal accumulation but that IRF4 expression is not crucial for Th2 and Th17 cell survival.",
keywords = "Animals, Mice, Gene Expression Regulation, Interferon Regulatory Factors/metabolism, Intestines, Th17 Cells, Th2 Cells, CD4-Positive T-Lymphocytes/cytology, Cell Movement",
author = "Constantin Schmidt and Aenne Harberts and Daniel Reimers and Tabea Bertram and Vo{\ss}, {Leonie Caroline} and Joanna Schmid and Lory, {Niels Christian} and Michael Spohn and Friedrich Koch-Nolte and Samuel Huber and Friederike Raczkowski and Minka Breloer and Hans-Willi Mittr{\"u}cker",
note = "Copyright {\textcopyright} 2023 Schmidt, Harberts, Reimers, Bertram, Vo{\ss}, Schmid, Lory, Spohn, Koch-Nolte, Huber, Raczkowski, Breloer and Mittr{\"u}cker.",
year = "2023",
doi = "10.3389/fimmu.2023.1182502",
language = "English",
volume = "14",
pages = "1182502",
journal = "FRONT IMMUNOL",
issn = "1664-3224",
publisher = "Lausanne : Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - IRF4 is required for migration of CD4+ T cells to the intestine but not for Th2 and Th17 cell maintenance

AU - Schmidt, Constantin

AU - Harberts, Aenne

AU - Reimers, Daniel

AU - Bertram, Tabea

AU - Voß, Leonie Caroline

AU - Schmid, Joanna

AU - Lory, Niels Christian

AU - Spohn, Michael

AU - Koch-Nolte, Friedrich

AU - Huber, Samuel

AU - Raczkowski, Friederike

AU - Breloer, Minka

AU - Mittrücker, Hans-Willi

N1 - Copyright © 2023 Schmidt, Harberts, Reimers, Bertram, Voß, Schmid, Lory, Spohn, Koch-Nolte, Huber, Raczkowski, Breloer and Mittrücker.

PY - 2023

Y1 - 2023

N2 - The transcription factor Interferon Regulatory Factor 4 (IRF4) is central in control of T cell activation and differentiation. Deficiency of IRF4 results in severe immune deficiency and affects maturation and function of most if not all T cell subsets. Here we use mouse infection models for Citrobacter rodentium and Strongyloides ratti to analyze the function of IRF4 in T helper (Th) 17 and Th2 cell responses, respectively. IRF4 deficient mice were impaired in the control of both pathogens, failed to mount Th17 and Th2 cell responses and showed impaired recruitment of T helper cells to the intestine, the infection site of both pathogens. Compromised intestinal migration was associated with reduced expression of the intestinal homing receptors α4β7 integrin, CCR9 and GPR15. Identification of IRF4 binding sites in the gene loci of these receptors suggests a direct control of their expression by IRF4. Competitive T cell transfer assays further demonstrated that loss of one functional Irf4 allele already affected intestinal accumulation and Th2 and Th17 cell generation, indicating that lower IRF4 levels are of disadvantage for Th2 and Th17 cell differentiation as well as their migration to the intestine. Conversion of peripheral CD4+ T cells from an Irf4 wildtype to an Irf4 heterozygous or from an Irf4 heterozygous to a homozygous mutant genotype after C. rodentium or S. ratti infection did not reduce their capacity to produce Th17 or Th2 cytokines and only partially affected their persistence in the intestine, revealing that IRF4 is not essential for maintenance of the Th2 and Th17 phenotype and for survival of these T helper cells in the intestine. In conclusion, we demonstrate that the expression levels of IRF4 determine Th2 and Th17 cell differentiation and their intestinal accumulation but that IRF4 expression is not crucial for Th2 and Th17 cell survival.

AB - The transcription factor Interferon Regulatory Factor 4 (IRF4) is central in control of T cell activation and differentiation. Deficiency of IRF4 results in severe immune deficiency and affects maturation and function of most if not all T cell subsets. Here we use mouse infection models for Citrobacter rodentium and Strongyloides ratti to analyze the function of IRF4 in T helper (Th) 17 and Th2 cell responses, respectively. IRF4 deficient mice were impaired in the control of both pathogens, failed to mount Th17 and Th2 cell responses and showed impaired recruitment of T helper cells to the intestine, the infection site of both pathogens. Compromised intestinal migration was associated with reduced expression of the intestinal homing receptors α4β7 integrin, CCR9 and GPR15. Identification of IRF4 binding sites in the gene loci of these receptors suggests a direct control of their expression by IRF4. Competitive T cell transfer assays further demonstrated that loss of one functional Irf4 allele already affected intestinal accumulation and Th2 and Th17 cell generation, indicating that lower IRF4 levels are of disadvantage for Th2 and Th17 cell differentiation as well as their migration to the intestine. Conversion of peripheral CD4+ T cells from an Irf4 wildtype to an Irf4 heterozygous or from an Irf4 heterozygous to a homozygous mutant genotype after C. rodentium or S. ratti infection did not reduce their capacity to produce Th17 or Th2 cytokines and only partially affected their persistence in the intestine, revealing that IRF4 is not essential for maintenance of the Th2 and Th17 phenotype and for survival of these T helper cells in the intestine. In conclusion, we demonstrate that the expression levels of IRF4 determine Th2 and Th17 cell differentiation and their intestinal accumulation but that IRF4 expression is not crucial for Th2 and Th17 cell survival.

KW - Animals

KW - Mice

KW - Gene Expression Regulation

KW - Interferon Regulatory Factors/metabolism

KW - Intestines

KW - Th17 Cells

KW - Th2 Cells

KW - CD4-Positive T-Lymphocytes/cytology

KW - Cell Movement

U2 - 10.3389/fimmu.2023.1182502

DO - 10.3389/fimmu.2023.1182502

M3 - SCORING: Journal article

C2 - 37469513

VL - 14

SP - 1182502

JO - FRONT IMMUNOL

JF - FRONT IMMUNOL

SN - 1664-3224

ER -